Cdc25B is an essential regulator for meiotic resumption in mouse oocytes. However, the role of this phosphatase during the later stage of the meiotic cell cycle is not known. In this study, we investigated the role of Cdc25B during metaphase II (MII) arrest in mouse oocytes. Cdc25B was extensively phosphorylated during MII arrest with an increase in the phosphatase activity toward Cdk1. Downregulation of Cdc25B by antibody injection induced the formation of a pronucleus-like structure. Conversely, overexpression of Cdc25B inhibited Ca 2+ -mediated release from MII arrest. Moreover, Cdc25B was immediately dephosphorylated and hence inactivated during MII exit, suggesting that Cdk1 phosphorylation is required to exit from MII arrest. Interestingly, this inactivation occurred prior to cyclin B degradation. Taken together, our data demonstrate that MII arrest in mouse oocytes is tightly regulated not only by the proteolytic degradation of cyclin B but also by dynamic phosphorylation of Cdk1.
INTRODUCTION
Mature mammalian oocytes are arrested at the metaphase of second meiosis (MII) by cytostatic factor (CSF) until fertilization. The molecular mechanism that controls this arrest depends on the regulation of M-phase promoting factor (MPF), a complex of Cdk1 and cyclin B. MPF activity is negatively regulated by the phosphorylations of two highly conserved residues of Cdk1, Thr14 and Tyr15 (Lew and Kornbluth, 1996) . In mouse oocytes, these inhibitory phosphorylations are catalyzed by the Wee1B kinase (Han et al., 2005) , whereas dephosphorylation (and hence activation of Cdk1) is mediated by dual-specificity phosphatase Cdc25B (Lincoln et al., 2002) . Although three isoforms of Cdc25s, Cdc25A, Cdc25B, and Cdc25C are expressed in mouse oocytes, Cdc25B has been known to be essential for meiosis resumption (Lincoln et al., 2002) . Therefore, it seems likely that MPF activity is regulated by a balance between the activity of the Wee1B kinase and the Cdc25B phosphatase. However, this is only the case for meiotic resumption. After oocytes have resumed meiosis and arrest at the MII stage, MPF activity is regulated by the steady-state level of cyclin B.
Upon fertilization, this steady-state is rapidly disrupted by the anaphase promoting complex/cyclosome (APC/C)-mediated degradation of cyclin B (Jones, 2005) . Thus, the current concept is that cyclin B turnover is the dominant mechanism for MPF regulation during MII arrest. However, mounting evidence suggests that Cdk1 phosphorylation also plays a critical role during MII arrest and exit. For instance, the depletion of Wee1B impairs the release from MII arrest (Oh et al., 2011) . Moreover, downregulation of Cdc25A activity induces pronuclear formation in mouse oocytes (Oh et al., 2013) , supporting the phosphorylation-dependent regulation of MPF during MII arrest. However, there is no direct evidence that Cdc25B is required for MII arrest, because Cdc25B null oocytes are arrested at prophase I stage (Lincoln et al., 2002) . Therefore, in this study, we investigated the role of Cdc25B during MII arrest in order to dissect the mechanism regulating Cdk1 phosphorylation in mouse oocytes.
MATERIALS AND METHODS

Animals
All mice used in this study were 3-to 5-week-old C57BL/6 female mice (Charles River or Daehan BioLink). Animals were maintained with food and water ad libitum under a 14-h light/10-h dark cycle. The guidelines of the Institutional Animal Care and Use Committees were followed for all animal procedures.
Oocyte collection GV oocytes were recovered from the ovaries of mice that had been administered 5IU of a pregnant mare's serum gonadotrophin (PMSG, Calbiochem). Oocytes were released from the ovaries by puncturing with a fine needle and were placed in M2 medium (Millipore) supplemented with 200 μM of IBMX (Sigma) to prevent GVBD. Only oocytes with an intact layer of cumulus cells were recovered, and cumulus cells were subsequently removed by repeated pipetting with a mouth-operated micropipette.
To obtain MI oocytes, the GV oocytes were washed extensively in IBMX-free M16 medium and cultured at 37°C in 5% CO 2 for 8 h.
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http://molcells.org Mol. Cells 515 MII oocytes were obtained from the superovulated mice with 5IU of PMSG followed by 5IU of human chorionic gonadotrophin (hCG, Sigma) 48 h apart. Ovulated oocytes were released from the ampullae of the oviducts at 16 h post-hCG. The cumulus cells were removed by a brief exposure to 0.1 mg/ml of hyaluronidase (Sigma) in M2 medium. Parthenogenetic activation of MII oocytes was achieved by washing the oocytes in Ca
2+
-free media containing 10 mM SrCl 2 (Sigma).
Microinjection
Oocytes were microinjected as described previously (Oh et al., 2010) . Briefly, antibodies (200 ng/μl) or cRNAs (500 ng/μl) were microinjected into the cytoplasm of MII oocytes in M2 medium. Approximately 10 pl of solution containing antibodies or cRNAs was injected per oocyte. Antibodies for microinjection were purchased from Santa Cruz (Cdc25B, sc-326; Cdc25C, sc-327). Following microinjection, oocytes were cultured in M16 medium (Millipore) at 37°C in 5% CO 2 atmosphere and a pronuclear formation was observed using an inverted microscope (DMI 4000B; Leica).
Preparation of Cdc25B cRNAs
The full-length cDNA encoding the mouse Cdc25B were purchased from Origene. The catalytically inactive mutants of Cdc25B (C483S) were generated using site-directed mutagenesis. cRNAs for microinjection were made in vitro using the mMESSAGE mMACHINE kit (Ambion). After in vitro transcription, cRNAs were immediately polyadenylated using the Poly (A) Tailing Kit (Ambion) and purified with the RNeasy Mini kit (Qiagen). The concentration of cRNAs was determined by OD260 and agarose gel electrophoresis.
RT-PCR
Total RNAs were extracted from GV, MI or MII oocytes using the RNeasy Plus Mini Kit (Qiagen) followed by reverse transcription (RT) using Sensiscript RT kit (Qiagen). PCR was performed using the following primers: for Cdc25B, GATGGAA-GTAGAGGAGC and CTTCCAGGGGTGTCACAC; for GAPDH, ACCACAGTCCATGCCATCAC and TCCACCACCCTGTTGC-TGTA. PCR conditions were as follows: denaturation at 95°C for 5 min, followed by 30 cycles of denaturation at 95°C for 30 s, annealing at 60°C for 30 sec, extension at 72°C for 30 s, and final extension at 72°C for 10 min.
Western blotting and immunostaining
For Western blotting, oocytes were collected in phosphate buffered saline (PBS) containing 1% polyvinylpyrrolidine (PVP) and frozen in SDS sample buffer. Western blotting was performed using antibodies against Cdc25B (Santa Cruz), cyclin B (Abcam) or α-tubulin (Abcam). For immunostaining, oocytes were fixed in 4% paraformaldehyde and permeabilized in 0.1% Triton X-100 in PBS. Oocytes were incubated with DAPI and FITC-conjugated Lens culinaris agglutinin (LCA) for DNA and cortical granule staining, respectively. Immunostaining was visualized using an inverted confocal microscope (TCS SP5; Leica).
Phosphatase activity assay
The activity of Cdc25B phosphatase was determined by the modified H1 kinase assay. Briefly, Cdc25B proteins were immunoprecipitated from GV or MII oocytes. GV oocytes were lysed in 5 μl of lysis buffer (10 μg/ml aprotinin, 10 μg/ml leupeptin, 10 mM p-nitrophenyl phosphate, 20 mM β-glycerophosphate, 0.1 mM sodium orthovanadate, and 5 mM EGTA) and preincubated with Cdc25B immunoprecipitates for 10 min. The kinase reaction was initiated by the addition of 5 μl of kinase buffer [24 mM p-nitrophenyl phosphate, 90mM β-glycerophosphate, 24 mM MgCl 2 , 24 mM EGTA, 0.2 mM EDTA, 4.6 mM sodium orthovanadate, 4 mM NaF, 1.6 mM dithiothreitol (DTT), 60 μg/ml aprotinin, 60 μg/ml leupeptin, 2.2 μM cAMP-dependent protein kinase inhibitor (PKI), 0.6 mM ATP, 2 mg/ml histone (type III-S; Sigma) with 500 μCi/ml γ-32 P]ATP (3,000 Ci/mmol; Amersham)]. The reaction was conducted for 10 min at 30°C and terminated by the addition of 10 μl of 2XSDS sample buffer and boiling for 3 min. Following SDS-PAGE, the gel was transferred to a PVDF membrane and analyzed by autoradiography.
Statistical analysis
Data are representative of at least three independent experiments unless otherwise specified. Values were analyzed by one-way ANOVA or Student's t-test, and p < 0.05 was considered statistically significant.
RESULTS
To investigate the role of Cdc25B during MII arrest, we first examined the expression of Cdc25B at different stages of meiotic maturation. RT-PCR analysis showed that Cdc25B mRNA expressed continuously during the meiotic cell cycle (Fig. 1A) . Consistent with this, immunoblotting analysis showed that Cdc25B protein was expressed from the germinal vesicle (GV) to MII stages with a dramatic mobility shift (Fig. 1B) , suggesting the post translational modifications during meiotic maturation. It has been known that Cdc25B undergoes a major mobility shift with an extensive phosphorylation during mitotic progression (Gabrielli et al., 1997) . Thus, we investigated whether Cdc25B is phosphorylated during the meiotic cell cycle in mouse oocytes. The mobility shift of Cdc25B during MII arrest was significantly decreased by the treatment of a protein phosphatase (Fig. 1C) , indicating that the increase in molecular weight of Cdc25B is due to the hyperphosphorylation. Next, to investigate the physiological meaning of the hyperphosphorylation of Cdc25B, we measured the phosphatase activity of Cdc25B at the GV and MII stages. Since Cdc25B dephosphorylates and hence activates Cdk1, we measured the activity of Cdk1 using histone H1 as the target substrate (Hassepass and Hoffmann, 2004; Tumurbaatar et al., 2011) . Interestingly, the Cdk1 activity was significantly increased when incubated with Cdc25B of MII oocyte lysates (Fig. 1D) , implying that Cdc25B phosphorylation during MII arrest is associated with an activation of Cdc25B. Consistent with our data, it has been reported that the hyperphosphorylation of Cdc25B is correlated with increased phosphatase activity in mitosis (Gabrielli et al., 1997) .
To examine the role of Cdc25B during MII arrest, specific neutralizing antibodies were injected into MII oocytes. Because Cdc25C is dispensable for the meiotic cell cycle (Chen et al., 2001) , antibody against Cdc25C was used as a negative control with normal IgG. Surprisingly, chromatins were dencondensed and subsequently a pronucleus-like structure was formed when the oocytes were injected with Cdc25B antibody (Fig. 2A) . Considering that the pronuclear structure is indicative of the progression of cell cycle from metaphase to interphase, this result indicates that oocytes were released from MII arrest. In contrast, little effect was shown in the oocytes injected with either normal IgG or Cdc25C antibody ( Fig. 2A) . Moreover, the formation of the pronucleus-like structure occurred without cortical granule exocytosis (Fig. 2B) , one of the earliest Ca 2+ -mediated events after egg activation (Tahara et al., 1996) , ex-
